BIOACTIVE

QR code - scan this to listen

BIOACTIVE

 4.9 via 145 ratings in Apple Podcasts, Spotify and Podcast Addict
Data: Rephonic
A science podcast from Riley D. Kirk, Ph.D.
Website: https://bioactivepodcast.com/

Dr. Riley Kirk is a cannabis research scientist and educator. She obtained her Ph.D. in pharmaceutical sciences, specializing in natural product chemistry, studying the traditional and contemporary uses of hundreds of medicinal plants. She is currently an assistant associate professor at the University of Rhode Island, has worked as an immunology scientist in the biotech industry, and works in the cannabis industry studying the chemical complexity of cannabis smoke.
Riley is also the co-founder of the cannabis research and education non-profit organization called the Network of Applied Pharmacognosy (NAP). Through NAP and on her podcast, Riley uses science as advocacy to research and communicate findings that highlight the unique power of natural products. The goal of Riley’s work is to unite people in the Cannabis industry, academia, and consumers to further the reach of Cannabis education and reduce harm.
Riley is passionate about making Cannabis science accessible through social media channels and alternative media which lead to Bioactive; an educational podcast which disseminates the chemistry and pharmacology of natural products. On this bi-weekly podcast, she covers current news and research surrounding cannabis, psychedelics, toxins, pharmaceuticals & other bioactive substances. Listen for special guests highlighting community stories.

© 881375 · more infoArtwork and data is from the podcast’s open RSS feed; we link directly to audio · Read our DMCA procedure
Megaphone
Hosted on Megaphone and measured by Chartable, Podder, Podscribe, Podsights, Podtrac, Spotify and Nielsen
This podcast may use tracking and attribution and dynamic content insertion

Stats: Statistics are produced by Megaphone, Chartable, Podder, Podscribe, Podsights, Podtrac and Spotify to help BIOACTIVE to understand how many downloads it is getting, or how many people are listening. Your device’s IP address and user agent is used to help calculate this figure. Megaphone and Podtrac are IAB v2 certified. Here is more detail about podcast statistics.

Tracking and attribution: Megaphone, Chartable, Podder, Podscribe, Podsights, Spotify and Nielsen or their partners may connect the fact you listened to this podcast to an action elsewhere on the internet. For example - they may spot a device that downloaded an episode of BIOACTIVE later visited the website of an advertiser; or they may track that a device that listened to BIOACTIVE also listened to a different show. This form of attribution is used to measure advertising effectiveness.

Dynamic content insertion: Megaphone may use limited data that they know about you - the device you’re using, the approximate location you’re in, or other data that can be derived from this, like the current weather forecast for your area - to change parts of the audio. BIOACTIVE may do this for advertising or for other forms of content, like news stories.

BIOACTIVE is able to use the above tools since its podcast host or measurement company offers this service. It doesn’t mean that this individual podcast uses them, or has access to this functionality. We use open data.

Other shows you may enjoy

Bite Me The Show About Edibles

Listen and follow

Keep up to date with Podnews for podcasting news, jobs and events every day

Get it free

Information for podcasters

Privacy: The player will download audio directly from Megaphone if you listen. That shares data (like your IP address or details of your device) with them.
Affiliate links: This page links to Apple Podcasts. We may receive a commission for purchases made via those links.
Cache: This podcast page made . Scheduled for update on . Rebuild this page now

close

Rebuild this page

Some parts of this page are cached. You can get the latest detail and links by solving the simple maths question below.

Get a global view on podcasting and on-demand with our daily news briefing